![Hai Ying Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hai Ying Wang
Directeur Technique/Scientifique/R&D chez Hrain Biotechnology Co., Ltd.
Profil
Hai Ying Wang is currently a Senior Director of Research & Development at Hrain Biotechnology Co., Ltd.
Prior to this, they earned a doctorate degree from Jilin University in 2012.
Postes actifs de Hai Ying Wang
Sociétés | Poste | Début |
---|---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Directeur Technique/Scientifique/R&D | - |
Formation de Hai Ying Wang
Jilin University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |